Fig. 4From: MediSyn: uncertainty-aware visualization of multiple biomedical datasets to support drug treatment selectionA use case. A case of the discovery of a drug-repurposing opportunity. Axitinib is promising to treat otherwise highly drug resistant mutation ABL1(T315I)-driven chronic myeloid leukemia based on pre-clinical evidence from both datasetsBack to article page